Skip to main content
Regeneron Pharmaceuticals, Inc.
Healthcare · Biotechnology
Made on Jul 17, 2026
Price at call $678.94
6-month call Neutral +0.1%
Target by Jan 2027 $679.73
Great value below $560.00
Model v0.3.0

Projection vs Actual (6M history + forecast)

Our straight 6-month prediction (bold) with a textured realism line, and the actual price overlaid from the prediction date forward.

Forecast

One directional 6-month call and the six monthly points we'll be scored against. Predicted Jul 17, 2026 8:02 am
Neutral REGN trends range-bound to $679.73 (+0.1% from $678.94) by Jan 2027.
Monthmonths after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $678.94 at call
Prediction made Jul 17, 2026 $678.94 at call
M1 Aug 17, 2026 $679.07 +0.0%
What actually happened: closed $803.48 on Aug 14, 2026 = +18.3% vs the call (predicted +0.0%)  ·  direction MISS (called flat, was up)  ·  off by 18.3 pp  ·  accuracy 4/10  ·  S&P +4.4% over the same window — lagged it
M2 Sep 17, 2026 $679.20 +0.0%
M3 Oct 17, 2026 $679.33 +0.1%
M4 Nov 17, 2026 $679.47 +0.1%
M5 Dec 17, 2026 $679.60 +0.1%
M6 Jan 17, 2027 $679.73 +0.1%

Deserved value (DCF/composite) is $683.37; over 6 months we project closing only part-way to it (reach 17.8%). Value-only — see Not Yet Modeled below.

Weaknesses

0 blocking · 0 degraded · 1 note — follow the chain top-down (cause → effect).
  • Note
    Valuation anchor absent: anchored_pe.
    anchor:anchored_pe

Equation Inputs

Everything feeding the v0.3.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$678.94
Composite fair value$607.98
Signal-adjusted fair value$577.72
DCF fair value$681.40
Anchored-PE fair value
Buy-below (value lens)$560.00
Value net score-79
Value confidence6 / 10
Quality net score+30
Memo confidence7 / 10
Deserved value (base)$644.69
Quality tilt+6%
Deserved value (used)$683.37
Coherence (value × quality)0.50

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 25.6%  3m 35.0%  6m 31.0%  
Daily σ (realism noise)2.2%
Beta vs S&P 500 1m -0.32  3m 0.21  5m 0.57  
Trailing 6-month return-10.5%

Knobs (equation params)

Deserved wt · DCF0.5
Quality tilt cap (±)0.2
Horizon reach (6mo)0.45
Coherence floor (conflict)0.5
Conviction gain / pt0.06
Realism mean-reversion φ0.85
Conviction floor0.4
Deserved wt · composite0.5
Realism vol window3m
Neutral band (%)5
Horizon (months)6
Realism σ fallback0.015

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.3.0 #6bd904191719

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Jul 17, 2026 freshest REGN-20260717-030002-286f
ext-forensic-memo Jul 17, 2026 freshest ext-REGN-20260717-055542-cea0
ext-lens-quality Jul 17, 2026 freshest ext-REGN-20260717-055542-cea0
ext-lens-value Jul 17, 2026 freshest ext-REGN-20260717-055542-cea0
scenario-valuation Jul 17, 2026 freshest REGN-20260717-030002-286f
valuation-synthesis Jul 17, 2026 freshest REGN-20260717-030002-286f

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 11, 2026 v0.6.0 Bear $808.05 $755.00 -6.6% Feb 2027 view
Jul 17, 2026 v0.3.0 Neutral $678.94 $679.73 +0.1% Jan 2027 viewing

Not Yet Modeled

What this v0.3.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Signal-adjusted fair value ($577.72) — the red-flag-adjusted anchor isn't the primary input yet (we use the raw DCF/composite blend, which double-counts DCF).
  • Recent momentum / drift — the line takes off straight; the trailing 6-month move (-10.5%) doesn't bend the slope.
  • Market beta — computed (1–5mo) for context but does not condition the path.
  • Earnings dates, catalysts, and known events — not modeled.
  • Macro regime & sector rotation — not modeled.
  • Horizon is a fixed 6-month assumption, not a modeled time-to-target.
  • Outcome scoring — predictions aren't yet graded against realized price once the evaluation date passes.